Orthocell Limited (ASX:OCC)
Australia · Delayed Price · Currency is AUD 0.9300
-0.0050 (-0.53%)
Feb 19, 2026, 2:21 PM AEST
Orthocell Market Cap
Orthocell has a market cap or net worth of 253.67 million as of February 18, 2026. Its market cap has decreased by -32.66% in one year.
Market Cap
253.67M
Enterprise Value
225.63M
Revenue
7.55M
Ranking
n/a
PE Ratio
n/a
Stock Price
0.93
Market Cap Chart
Since August 12, 2014, Orthocell's market cap has increased from 29.70M to 253.67M, an increase of 754.12%. That is a compound annual growth rate of 20.45%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 17, 2026 | 249.60M | -15.21% |
| Dec 31, 2025 | 294.37M | -9.37% |
| Dec 31, 2024 | 324.80M | 297.55% |
| Dec 29, 2023 | 81.70M | 1.05% |
| Dec 30, 2022 | 80.85M | -19.58% |
| Dec 31, 2021 | 100.54M | 20.90% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Clinuvel Pharmaceuticals | 582.83M |
| Immutep | 567.38M |
| Racura Oncology | 393.93M |
| Dimerix | 288.19M |
| Starpharma Holdings | 201.56M |
| Tetratherix | 196.97M |
| Recce Pharmaceuticals | 170.62M |
| Actinogen Medical | 147.13M |